Table 6.
Using of medication in comparing AGV with BGI
| Studies of subgroups | No. of studies | No. of eyes | WMD (95 % CI) | Heterogeneity | Test for over effect (P) | |
|---|---|---|---|---|---|---|
| I2 (%) | P | |||||
| Short-term follow-ups | ||||||
| Total | 3 | 558 | 0.29 (0.07–0.50) | 0 | 0.43 | 0.009 |
| RCT | 2 | 477 | 0.35 (0.11–0.59) | 0 | 0.68 | 0.004 |
| Non-RCT | 1 | 81 | 0.00 (−0.50–0.50) | / | / | 1 |
| Children | 0 | / | / | / | / | / |
| Adults | Same as RCT group | |||||
| Long-term follow-ups | ||||||
| Total | 7 | 659 | 0.42 (0.22–0.62) | 4 | 0.40 | 0.000 |
| Sensitivity analysis | 6 | 651 | 0.43 (0.24–0.62) | 0 | 0.45 | 0.000 |
| RCT | 2 | 340 | 0.56 (0.26–0.85) | 0 | 0.32 | 0.000 |
| Non-RCT | 5 | 319 | 0.33 (0.08–0.57) | 0 | 0.42 | 0.01 |
| Children | 3 | 85 | 0.20 (−0.40–0.80) | 7 | 0.34 | 0.51 |
| Adults | Same as RCT group | |||||